Merck Announces Supply Agreement with U.S. Government for Molnupiravir, an Investigational Oral Antiviral Candidate for Treatment of Mild to Moderate COVID-19 Pharmaceutical Investing
U.S. FDA Approves PREVNAR 20, Pfizer's Pneumococcal 20-valent Conjugate Vaccine for Adults Ages 18 Years or Older Pharmaceutical Investing
Allergan Aesthetics and BOTOX® Cosmetic Put Real Stories at the Forefront in New Campaign Biotech Investing
Bausch + Lomb and Lochan Enter Into Agreement to Develop the Next-Generation of eyeTELLIGENCE Clinical Decision Support Software Medical Device Investing
Bausch Health Announces Early Tender Results And Early Settlement Date For Cash Tender Offer For Senior Secured Notes Medical Device Investing
CAPTIVATE Study Shows an IMBRUVICA® Plus VENCLEXTA®/VENCLYXTO® Chemotherapy-Free Combination Has Potential to Provide Remission After Fixed-Duration Treatment for Chronic Lymphocytic Leukemia Biotech Investing
Aurinia Announces Additional Analysis of its AURORA 1 Phase 3 Study Data Presented at ERA-EDTA 2021 Congress Biotech Investing
Health Canada Approves AbbVie's RINVOQ® for the Treatment of Adults with Active Psoriatic Arthritis Biotech Investing
New Data on KEYTRUDA® Plus LENVIMA® Versus Sunitinib in First-Line Treatment for Patients With Advanced Renal Cell Carcinoma From Pivotal Phase 3 CLEAR/KEYNOTE-581 Trial Presented at 2021 ASCO Annual Meeting Pharmaceutical Investing
